NORONHA, L. The urgency to treat optimally and to target: Avoiding long-term complications in type 2 diabetes with a focus on GLP-1 receptor agonists. Canadian Primary Care Today, Toronto, Canada, v. 1, n. S07, p. 2–6, 2023. DOI: 10.58931/cpct.2023.1S0717. Disponível em: https://canadianprimarycaretoday.com/article/view/1-s07-noronha. Acesso em: 22 jan. 2025.